Evidence map›Paper›PMID 29608569›Full record

ArticlePLoS neglected tropical diseases2018

Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping.

Fernanda Cristina Costa, Amanda Fortes Francisco, Shiromani Jayawardhana, Simone Guedes Calderano, Michael D Lewis, Francisco Olmo, Tom Beneke, Eva Gluenz, Jack Sunter, Samuel Dean and 2 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Statins do not reduce the parasite burden during experimentalAntimicrobial agents and chemotherapy · 2025
    Article
  10. Discovery and Early Optimization of 1Journal of medicinal chemistry · 2025
    Article
  11. Article
  12. Reporter genes and transgenicFrontiers in medicine · 2025
    Review
  13. Article
  14. Stage-specific MCM protein expression inFrontiers in cellular and infection microbiology · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Fernanda Cristina CostaFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0001-7108-3278
Amanda Fortes FranciscoFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Shiromani JayawardhanaFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Simone Guedes CalderanoFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Michael D LewisFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Francisco OlmoFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Tom BenekeSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Eva GluenzSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-4346-8896
Jack SunterDepartment of Biological and Medical Sciences, Oxford Brookes University, Oxford, United Kingdom.
Samuel DeanSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
John Morrison KellyFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Martin Craig TaylorFaculty of Infectious and Tropical diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID 0000-0003-4147-0693
London School of Hygiene & Tropical Medicine · GBUniversity of Oxford · GBInstituto Butantan · BROxford Brookes University · GBUniversidade de São Paulo · BR

Funding

British Heart Foundation PG/13/88/30556Medical Research Council MR/N017323/1Wellcome Trust
6 · The paper itself

Abstract

backgroundInfection with Trypanosoma cruzi causes Chagas disease, a major public health problem throughout Latin America. There is no vaccine and the only drugs have severe side effects. Efforts to generate new therapies are hampered by limitations in our understanding of parasite biology and disease pathogenesis. Studies are compromised by the complexity of the disease, the long-term nature of the infection, and the fact that parasites are barely detectable during the chronic stage. In addition, functional dissection of T. cruzi biology has been restricted by the limited flexibility of the genetic manipulation technology applicable to this parasite. METHODOLOGY/PRINCIPAL

findingsHere, we describe two technical innovations, which will allow the role of the parasite in disease progression to be better assessed. First, we generated a T. cruzi reporter strain that expresses a fusion protein comprising red-shifted luciferase and green fluorescent protein domains. Bioluminescence allows the kinetics of infection to be followed within a single animal, and specific foci of infection to be pinpointed in excised tissues. Fluorescence can then be used to visualise individual parasites in tissue sections to study host-parasite interactions at a cellular level. Using this strategy, we have been routinely able to find individual parasites within chronically infected murine tissues for the first time. The second advance is the incorporation of a streamlined CRISPR/Cas9 functionality into this reporter strain that can facilitate genome editing using a PCR-based approach that does not require DNA cloning. This system allows the rapid generation of null mutants and fluorescently tagged parasites in a background where the in vivo phenotype can be rapidly assessed. CONCLUSIONS/SIGNIFICANCE: The techniques described here will have multiple applications for studying aspects of T. cruzi biology and Chagas disease pathogenesis previously inaccessible to conventional approaches. The reagents and cell lines have been generated as a community resource and are freely available on request.

Indexed as

CRISPR-Cas SystemsAnimalsChagas DiseaseFemaleFluorescenceGenes, ReporterGreen Fluorescent ProteinsHumansLuminescent MeasurementsMiceMice, Inbred BALB CPhenotypeTrypanosoma cruziGreen Fluorescent Proteins

Identifiers

PMID29608569
PMCPMC5897030
OpenAlexW2795655481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.